Reducing Up-set Stomach and Vomiting After Surgery Using Essential Oils
Launched by UNIVERSITY OF ROCHESTER · Dec 7, 2017
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
If participants decide to take part in this study, they will be asked to use choose a small nasal inhaler from a bag, open the sealed package, and inhale from the nasal inhaler 3 times, inhaling through the nose and exhaling through the mouth, just prior to entering the operating room. During recovery in the Post-operative acute care unit (PACU), nausea severity will be rated using a 0-3 scale where zero indicates no nausea.
If your score is 1-3, participants will be instructed/assisted in using a nasal inhaler 3 times, inhaling through the nose and exhaling through the mouth. After 5 minu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • post-op surgical patients at least 18 years of age or older
- • the ability to understand and follow directions for use of essential oils
- • the ability to understand and give informed consent to study
- • the ability to understand, read and write English
- • ambulatory or short-stay/23-hour patients
- Exclusion Criteria:
- • History of any pulmonary disease, including but not limited to: asthma, COPD, OSA, chronic bronchitis, pulmonary and ear, nose, throat (ENT) surgery patients
- • Allergy to any of the ingredients in the essential oils
- • Sensitivity to strong odors
About University Of Rochester
The University of Rochester is a leading academic institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in education, research, and clinical practice, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications in healthcare. With a focus on diverse therapeutic areas, the University of Rochester aims to enhance treatment options and outcomes for patients while contributing to the broader scientific community through rigorous study design and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Patients applied
Trial Officials
Maxine Fearrington, MS
Principal Investigator
University of Rochester, Strong Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials